Arrowhead Pharmaceuticals (ARWR) Q1 2017 Earnings

6FebConfirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-0.37
-0.27
-0.18
-0.08

Details

Expected EPS
-0.2
Actual EPS
-0.17
Surprise EPS
0.03
Surprise Percent
+15%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.17 per share for Q1 2017.

0 Comments

Share your thoughts